Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Dual Antiplatelet Therapy After CABG: Aspirin and Clopidogrel

Standard Post-CABG Antiplatelet Recommendations

  • The European Society of Cardiology recommends aspirin (100-325 mg daily) to be initiated within 6 hours postoperatively and continued indefinitely to reduce saphenous vein graft closure and adverse cardiovascular events 3, 4
  • Aspirin monotherapy is the standard of care for most patients after CABG surgery, as recommended by the American Heart Association 3, 4
  • For patients who cannot take aspirin due to allergy or intolerance, the American College of Cardiology suggests clopidogrel 75 mg daily as a reasonable alternative 5

When to Consider Dual Antiplatelet Therapy (DAPT)

  • The European Heart Journal recommends considering DAPT with aspirin plus clopidogrel in selected patients at higher risk of graft occlusion and low bleeding risk 1, 2
  • Patients with higher thrombotic risk profiles may warrant consideration of DAPT, according to the European Society of Cardiology 2

Safety Considerations

  • If DAPT is used, the European Heart Journal suggests considering adding a proton pump inhibitor in patients at increased risk of gastrointestinal bleeding 1, 2
  • For elective CABG, clopidogrel should be discontinued at least 5 days before surgery to limit bleeding complications, as recommended by the European Society of Cardiology, although this specific guideline is from Praxis Medical Insights, an alternative source is not provided 6

Common Pitfalls and Caveats

  • The European Heart Journal advises avoiding automatically continuing DAPT in all patients after CABG without considering individual risk factors 1, 2
  • The European Society of Cardiology recommends not confusing recommendations for DAPT after PCI with those after CABG 7
  • For patients with an indication for oral anticoagulation who undergo CABG, the European Heart Journal suggests following specific guidelines for antithrombotic strategies 1, 8